scholarly journals Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis

2017 ◽  
Vol Volume 10 ◽  
pp. 993-1000 ◽  
Author(s):  
Tao Chen ◽  
Hui Wang ◽  
Peng Yang ◽  
Zhen-Yu He
Keyword(s):  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Meta Analysis ◽  
Prognostic Role

scholarly journals Prognostic role of long noncoding RNA ZFAS1 in cancer patients: a systematic review and meta-analysis

Oncotarget ◽  
2017 ◽  
Vol 8 (59) ◽  
pp. 100490-100498 ◽  
Author(s):  
Tian Lan ◽  
Xiong Lan ◽  
Guangcai Li ◽  
Zhen Zheng ◽  
Minghua Zhang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Cancer Patients ◽  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Meta Analysis ◽  
Prognostic Role

scholarly journals Prognostic Role of Long Noncoding RNA BANCR in Solid Tumors: A Meta-Analysis

2017 ◽  
Vol 16 (6) ◽  
pp. 727-735
Author(s):  
Jun Zhao ◽  
Yali Qi ◽  
Jiahao Hu ◽  
Wenwen Dai ◽  
Yifei Chen
Keyword(s):  
Solid Tumors ◽  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Meta Analysis ◽  
Prognostic Role

scholarly journals Letter to the editor regarding the article “Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis”

2017 ◽  
Vol Volume 10 ◽  
pp. 2823-2824
Author(s):  
He Yu ◽  
Peng Wang ◽  
Xiong Zhang
Keyword(s):  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Meta Analysis ◽  
Prognostic Role ◽  
Letter To The Editor

scholarly journals The prognostic role of long noncoding RNA CRNDE in cancer patients: a systematic review and meta-analysis

Neoplasma ◽  
2019 ◽  
Vol 66 (01) ◽  
pp. 73-82 ◽  
Author(s):  
W. Wang ◽  
F. Yuan ◽  
J. Xu
Keyword(s):  
Systematic Review ◽  
Cancer Patients ◽  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Meta Analysis ◽  
Prognostic Role

scholarly journals Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Yao Wei ◽  
Ben Niu
Keyword(s):  
Prognostic Factor ◽  
Noncoding Rna ◽  
Prognostic Value ◽  
Meta Analysis ◽  
Disease Free Survival ◽  
Tumor Type ◽  
Prognostic Role ◽  
Hazard Ratios ◽  
Patient Prognosis

Objectives. The expression of metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a highly abundant and ubiquitously expressed long noncoding RNA (lncRNA), influences clinical parameters and may have prognostic value in cancer. This meta-analysis evaluated the prognostic role of MALAT1 in various cancers.Materials and Methods. Systematic literature searches of PubMed and EMBASE databases were conducted for eligible studies of the prognostic role of MALAT1 in cancer. Overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were analyzed. Summary hazard ratios (HRs) and 95% confidence intervals (95% CIs) were assessed to evaluate the influence of MALAT1 expression on patient prognosis.Results. Nine studies with a total of 932 patients were included in the analysis. Elevated MALAT1 expression was significantly correlated with poor OS (HR 2.02; 95% CI: 1.62–2.52;P<0.001;I2=0%). Subgroup analysis indicated that tumor type, histology type, ethnicity, and measurement technique did not affect the prognostic value of MALAT1 for OS. The HR of elevated MALAT1 for DFS was 2.78 (95% CI: 1.87–4.15;P<0.001;I2=0%).Conclusions. Elevated MALAT1 expression is correlated with poor OS in various types of cancer, suggesting that this gene is a prognostic factor for different types of cancer.

Prognostic and clinicopathological role of long noncoding RNA NORAD in various cancers: a meta-analysis

2021 ◽  
Vol 15 (6) ◽  
pp. 427-436
Author(s):  
Qingting Wang ◽  
Qianqian Zhang ◽  
Jian Wang ◽  
Wei Feng ◽  
Yuqian Chen ◽  
...  
Keyword(s):  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Meta Analysis ◽  
Clinicopathological Characteristics ◽  
Positive Lymph Node ◽  
Large Tumor ◽  
Knowledge Infrastructure ◽  
Differentiation Degree ◽  
Poor Differentiation

Aim: Long noncoding RNA (lncRNA) noncoding RNA activated by DNA damage (NORAD) is widely investigated in different tumors. Our meta-analysis intends to assess the prognostic and clinicopathological value of NORAD in cancers. Materials & methods: We searched PubMed, Web of Science, Embase and Chinese National Knowledge Infrastructure from inception to 1 August 2020. Results: The results showed that higher expression of NORAD had a significant association with worse overall survival. Additionally, correlations were detected between elevated level of NORAD and poor differentiation degree, positive lymph node metastasis and large tumor size in cancer patients. Conclusion: LncRNA NORAD can serve as a novel and promising biomarker for prognosis and clinicopathological characteristics in different cancers.

scholarly journals Role of long noncoding RNA UCA1 as a common molecular marker for lymph node metastasis and prognosis in various cancers: a meta-analysis

Oncotarget ◽  
2016 ◽  
Vol 8 (1) ◽  
pp. 1937-1943 ◽  
Author(s):  
Anbang He ◽  
Rong Hu ◽  
Zhicong Chen ◽  
Xinhui Liao ◽  
Jianfa Li ◽  
...  
Keyword(s):  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Molecular Marker ◽  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Meta Analysis ◽  
Node Metastasis

scholarly journals The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis

2016 ◽  
Vol 27 ◽  
pp. iv41
Author(s):  
F. Passiglia ◽  
A. Galvano ◽  
S. Rizzo ◽  
A. Listì ◽  
N. Barraco ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Systematic Review ◽  
Liver Metastasis ◽  
Surgical Resection ◽  
Meta Analysis ◽  
Prognostic Role ◽  
Colorectal Cancer Liver Metastasis

scholarly journals Prognostic role of anemia in heart failure with preserved ejection fraction: A systematic review and meta-analysis

2021 ◽  
Author(s):  
Monil Majmundar ◽  
Rajkumar Doshi ◽  
Harshvardhan Zala ◽  
Palak Shah ◽  
Devina Adalja ◽  
...  
Keyword(s):  
Heart Failure ◽  
Systematic Review ◽  
Ejection Fraction ◽  
Meta Analysis ◽  
Preserved Ejection Fraction ◽  
Prognostic Role

scholarly journals Involvement of the long noncoding RNA H19 in osteogenic differentiation and bone regeneration

2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Zimo Zhou ◽  
Mohammad Showkat Hossain ◽  
Da Liu
Keyword(s):  
Bone Regeneration ◽  
Osteogenic Differentiation ◽  
Long Noncoding Rna ◽  
Noncoding Rna ◽  
Osteoblast Differentiation ◽  
Osteoclast Differentiation ◽  
Complex Processes ◽  
Osteogenic Induction ◽  
Novel Target

AbstractOsteogenic differentiation and bone regeneration are complex processes involving multiple genes and multiple steps. In this review, we summarize the effects of the long noncoding RNA (lncRNA) H19 on osteogenic differentiation.Osteogenic differentiation includes matrix secretion and calcium mineralization as hallmarks of osteoblast differentiation and the absorption of calcium and phosphorus as hallmarks of osteoclast differentiation. Mesenchymal stem cells (MSCs) form osteoprogenitor cells, pre-osteoblasts, mature osteoblasts, and osteocytes through induction and differentiation. lncRNAs regulate the expression of coding genes and play essential roles in osteogenic differentiation and bone regeneration. The lncRNA H19 is known to have vital roles in osteogenic induction.This review highlights the role of H19 as a novel target for osteogenic differentiation and the promotion of bone regeneration.

Sign in / Sign up

Export Citation Format

Share Document